A Study of Lasmiditan in Healthy Japanese and Caucasian Participants

Inclusion Criteria: * Are overtly healthy Japanese (first generation) or Caucasian males or females, as determined by medical history and physical examination * Have a body mass index of 18.0 to 32.0 kilograms per square meter (kg/m²), inclusive Exclusion Criteria: * Have known allergies to lasmiditan, related compounds or any components of the formulation of lasmiditan * Have previously received the investigational product in this study, withdrawn from this study, or received lasmiditan in any other study investigating lasmiditan * Have an abnormal supine blood pressure at screening. * Have a history of syncope, presyncope, uncontrolled vertigo, postural dizziness, or a risk of falls, as judged to be clinically significant by the investigator, or have orthostatic decreases in supine blood pressure of \>20 millimeters of mercury (mmHg), or have orthostatic decreases in diastolic blood pressure of \>10 mmHg at screening. * Are women who are pregnant, lactating, or have a positive pregnancy test at screening or admission to the clinical research unit (CRU) * Have donated blood of more than 500 milliliters (mL) within 1 month prior to screening